Thus, our data suggest that induction of an acute — more than a chronic — inflammatory TME stimulated by ADAR1 inhibition might contribute to cancer cell death by inducing both cell cycle arrest and antitumor immune responses. The gene discussed is ADAR; the disease is cancer.